Results 71 to 80 of about 193,845 (166)
Contributions to Tobacco and Nicotine Research, 2023 Nicotine polacrilex (CAS-No. 96055-45-7) can be used as the source of nicotine in nicotine pouches and other oral nicotine delivery products such as lozenges, tablets, and gums.
Moldoveanu Serban C.
doaj +1 more source
CA: A Cancer Journal for Clinicians, Volume 76, Issue 4, July/August 2026.Abstract This article provides updated global cancer statistics for the year 2024 based on the GLOBOCAN estimates of the International Agency for Research on Cancer. The authors describe national cancer incidence and mortality by world region and the Human Development Index and predict the burden in 2050 based on demographic trends.
Hyuna Sung +7 more
wiley +1 more source
Flavored nicotine pouch use in the United States: Mint represents the leading flavor
Preventive Medicine ReportsObjective: Nicotine pouches are an emerging tobacco product available in a variety of flavors. We examined flavor preferences among adults who used nicotine pouches in the past 30 days and identified characteristics associated with flavored-only versus ...
Julia N. Soulakova, Lisa J. Crockett
doaj +1 more source
Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 6, Page 1113-1123, June 2026.Combined exposure to gestational diabetes and maternal smoking was associated with a shorter duration of pregnancy and a higher risk of preterm birth and delayed hospital discharge. Both exposures independently exerted adverse effects, evident even in a predominantly low‑risk population.
Lotta S. Holopainen +4 more
wiley +1 more source
Brief Survey of Current Oral Tobacco and Nicotine Product Use in Sweden and Denmark
Contributions to Tobacco and Nicotine ResearchExclusive use of Swedish snus is associated with a reduction in associated health risks as compared with cigarette smoking. Similar to Swedish snus but without tobacco, modern oral nicotine pouches are smokeless nicotine products with the potential to ...
Prasad Krishna, Edward Lauren
doaj +1 more source
From Pharmaceutical to Biophysical Therapies: New Horizons in Inflammatory Bowel Disease Management
JCC Plus, Volume 1, Issue 2, March 2026.Important limitations exist in the current pharmacological landscape of Inflammatory Bowel Disease (IBD), such as variable response rates and treatment‐limiting adverse effects. In this review, we perform a critical assessment of the current literature on novel multimodal biophysical approaches showing alternative mechanisms of action to, and potential
Benedetta Ricchi +7 more
wiley +1 more source
The Milbank Quarterly, Volume 104, Issue 1, Page 76-115, March 2026.Policy Points Ultraprocessed foods (UPFs) are engineered to heighten reward and accelerate delivery of reinforcing ingredients, driving compulsive consumption and disrupting appetite regulation. This is a growing challenge for health policy. UPFs share key engineering strategies adopted from the tobacco industry, such as dose optimization and hedonic ...
ASHLEY N. GEARHARDT +2 more
wiley +1 more source
The changing face of nicotine use in England: Age‐specific annual trends, 2014 to 2024
Addiction, Volume 121, Issue 3, Page 549-563, March 2026.Abstract Aims To examine age‐specific trends in patterns of nicotine use in England between 2014 and 2024, including types of products used, exclusive and dual use of smoking and vaping, smoking frequency and the smoking history of those who vape.
Sarah E. Jackson +6 more
wiley +1 more source
Tobacco Smoking and Smoke‐Free Products as Risk Factors for Dental Implants: A Systematic Review
Clinical Oral Implants Research, Volume 37, Issue 3, Page 262-286, March 2026.ABSTRACT Objectives This systematic review aimed to investigate the effect of tobacco smoking and smoke‐free products as risk factors for dental implants. Materials and Methods Three databases were searched to identify studies reporting on the risk of implant failure/survival in tobacco smokers or smoke‐free users as compared to non‐smokers in studies ...
Calciolari Elena +4 more
wiley +1 more source